Volume 23, Number 8—August 2017
Research
Clinical Laboratory Values as Early Indicators of Ebola Virus Infection in Nonhuman Primates
Table 1
Variable |
Models of infection |
||||
---|---|---|---|---|---|
Rhesus macaque with |
p value† |
Cynomolgus macaque with Kikwit strain, n = 6 |
p value‡ |
||
Kikwit strain, n = 18 |
Makona strain, n = 6 |
||||
Baseline characteristic | |||||
Weight, kg | 4.92 | 4.79 | 0.894 | 4.44 | 0.526 |
Age, y |
3.94 |
3.49 |
0.575 |
4.92 |
0.107 |
Postchallenge clinical data | |||||
Survival time, h | 186.9 | 337.5 | 0.005 | 175.2 | 0.739 |
Clinical responsiveness score, d§ | |||||
3 | 0 | 0 | None | 0 | None |
5 | 0.56 | 0 | 0.078 | 0.55 | 0.729 |
7 | 1.64 | 0.17 | 0.004 | 2.60 | 0.059 |
Presence of petechial rash, d | 5.65 | 8.17 | <0.001 | 5.17 | 0.265 |
Decreased food consumption, d | 5.11 | 8.33 | <0.001 | 4.67 | 0.178 |
Presence of anuria, d | 6.43 | 8.20 | 0.008 | 6.40 | 0.500 |
*Data are means.
†For rhesus macaque model with Ebola virus (EBOV) Kikwit strain vs. Makona strain. Bold indicates p<0.05.
‡For rhesus macaque model with EBOV Kikwit strain vs. cynomolgus macaque model with EBOV Kikwit strain.
§Clinical Responsiveness Score: 0 = active, 1 = decreased activity; 2 = mildly unresponsive (becomes active when approached), occasional prostration; 3 = moderate unresponsiveness (may require prodding to respond), weakness; 4 = moderate to severe unresponsiveness (requires prodding), moderate prostration; 5 = moribund, severe unresponsiveness, pronounced prostration.
Page created: July 17, 2017
Page updated: July 17, 2017
Page reviewed: July 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.